» Articles » PMID: 39634568

SnoRNAs: The Promising Targets for Anti-tumor Therapy

Overview
Journal J Pharm Anal
Specialty Chemistry
Date 2024 Dec 5
PMID 39634568
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, small nucleolar RNAs (snoRNAs) have transcended the genomic "noise" to emerge as pivotal molecular markers due to their essential roles in tumor progression. Substantial evidence indicates a strong association between snoRNAs and critical clinical features such as tumor pathology and drug resistance. Historically, snoRNA research has concentrated on two classical mechanisms: 2'--ribose methylation and pseudouridylation. This review specifically summarizes the novel regulatory mechanisms and functional patterns of snoRNAs in tumors, encompassing transcriptional, post-transcriptional, and post-translational regulation. We further discuss the synergistic effect between snoRNA host genes (SNHGs) and snoRNAs in tumor progression. More importantly, snoRNAs extensively contribute to the development of tumor cell resistance as oncogenes or tumor suppressor genes. Accordingly, we provide a comprehensive review of the clinical diagnosis and treatment associated with snoRNAs and explore their significant potential as novel drug targets.

Citing Articles

Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.

References
1.
Huldani H, Gandla K, Asiri M, Romero-Parra R, Alsalamy A, Hjazi A . A comprehensive insight into the role of small nucleolar RNAs (snoRNAs) and SNHGs in human cancers. Pathol Res Pract. 2023; 249:154679. DOI: 10.1016/j.prp.2023.154679. View

2.
Lan T, Yuan K, Yan X, Xu L, Liao H, Hao X . LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Cancer Res. 2019; 79(13):3220-3234. DOI: 10.1158/0008-5472.CAN-18-4044. View

3.
Siprashvili Z, Webster D, Johnston D, Shenoy R, Ungewickell A, Bhaduri A . The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer. Nat Genet. 2015; 48(1):53-8. PMC: 5324971. DOI: 10.1038/ng.3452. View

4.
Yang H, Villani R, Wang H, Simpson M, Roberts M, Tang M . The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018; 37(1):266. PMC: 6211502. DOI: 10.1186/s13046-018-0909-x. View

5.
Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J . Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res. 2010; 39(2):675-86. PMC: 3025573. DOI: 10.1093/nar/gkq776. View